During the past decade, Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica" are "Solid Tumors" (3 trials), "ALK Fusion-positive Solid or CNS Tumors" (1 trials), "CNS Tumors" (1 trials), "Leukemia" (1 trials) and "Lymphoblastic Lymphoma, Childhood" (1 trials). Many other conditions were trialed in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica" in a lesser frequency.

Most popular intervention types in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica" are "Drug" (8 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (2 trials), "Atezolizumab" (2 trials), "Entrectinib" (2 trials), "6-Mercaptopurine" (1 trials) and "Belvarafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica, 4 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".